News Releases

Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.

Mayo Clinic Laboratories, a leading reference laboratory, and Helix, the nation’s leading population genomics and viral surveillance company, today announced a new strategic collaboration that will provide life sciences customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle. 

Mayo Clinic Laboratories, a leader in gastroenterology and patient care, will be exhibiting at the Crohn's & Colitis Congress, a premier conference for health care professionals and researchers interested in inflammatory bowel disease (IBD). Mayo Clinic Laboratories offers a comprehensive IBD test menu, including evaluations to diagnose, differentiate, and manage therapies to treat the condition.

As Tropical Storm Nicole approaches Florida, the Mayo Clinic Laboratories Florida location will close tonight, Nov. 9, at 7:30 p.m. ET, as a safety precaution. The location will remain closed through 7:30 p.m. ET tomorrow, Nov. 10.

Darci Block, Ph.D., co-director of the Central Clinical Lab in Mayo Clinic’s Department of Laboratory Medicine and Pathology in Rochester, Minnesota, discusses how and when autoverification is used and not used to help verify the approximately 8,000 specimens that are sent to the department’s Central Clinical Lab every day.

William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, shares his concerns about the VALID Act, which if passed would give the FDA oversight of laboratory-developed tests. VALID could hamper labs’ test development activity, increase costs for labs, and disproportionately affect smaller labs or those with fewer resources. It could also lead to more test development partnerships and lab collaboration.

Results of a new study by researchers at Mayo Clinic and Washington State University show that hydrogen peroxide-producing e-bandages may be an effective alternative to antibiotics for managing infected wounds.  

Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt Sause, president and CEO of Roche Diagnostics North America, explain how the well-intended Protecting Access to Medicare Act of 2014 (PAMA) puts vital diagnostic tests at risk.

Mayo Clinic Laboratories has validated the Centers for Disease Control and Prevention's test kit for monkeypox and will begin to ramp up testing.

Mayo Clinic is the first and only PCD Foundation accredited center for the diagnosis of primary ciliary dyskinesia, a rare and debilitating lung disease.

Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in developing and implementing new tests — but never on such an aggressive timeline.

The Department of Health and Human Services has named Mayo Clinic Laboratories as one of five commercial laboratories to expand access and capacity for monkeypox testing.

Today's Highlights Include: Walz signs ALS bill by senator with the disease, Health Fusion: A farm family's journey from tragedy to gratefulness through organ donation, and google Search will soon let you book checkups and other medical appointments.